|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wadhwa R, Taketa T, Sudo K, Blum MA and
Ajani JA: Modern oncological approaches to gastric adenocarcinoma.
Gastroenterol Clin North Am. 42:359–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ashraf N, Hoffe S and Kim R: Adjuvant
treatment for gastric cancer: Chemotherapy versus radiation.
Oncologist. 18:1013–1021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghosh S: Cisplatin: The first metal based
anticancer drug. Bioorg Chem. 88:1029252019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen LL: Linking long noncoding RNA
localization and function. Trends Biochem Sci. 41:761–772. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu M, Huang Y, Chen T, Wang W, Yang S, Ye
Z and Xi X: lncRNA MEG3 inhibits the progression of prostate cancer
by modulating miR-9-5p/QKI-5 axis. J Cell Mol Med. 23:29–38. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao W, Weng T, Wang L, Shi B, Meng W, Wang
X, Wu Y, Jin L and Fei L: Long non-coding RNA NORAD promotes cell
proliferation and glycolysis in non-small cell lung cancer by
acting as a sponge for miR1365p. Mol Med Rep. 19:5397–5405.
2019.PubMed/NCBI
|
|
12
|
Xu N, Qiao L, Yin L and Li H: Long
noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and
induces epithelial-mesenchymal transition by sponging miR-375. J
BUON. 24:2273–2279. 2019.PubMed/NCBI
|
|
13
|
Zhang M, Jiang X, Jiang S, Guo Z, Zhou Q
and He J: lncRNA FOXD2-AS1 regulates miR-25-3p/Sema4c axis to
promote the invasion and migration of colorectal cancer cells.
Cancer Manag Res. 11:10633–10639. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xi Z, Si J and Nan J: lncRNA MALAT1
potentiates autophagy-associated cisplatin resistance by regulating
the microRNA-30b/autophagy-related gene 5 axis in gastric cancer.
Int J Oncol. 54:239–248. 2019.PubMed/NCBI
|
|
15
|
Guo Y, Yue P, Wang Y, Chen G and Li Y:
PCAT-1 contributes to cisplatin resistance in gastric cancer
through miR-128/ZEB1 axis. Biomed Pharmacother. 118:1092552019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L and Wang S: Long non-coding RNA
OIP5-AS1 knockdown enhances CDDP sensitivity in osteosarcoma via
miR-377-3p/FOSL2 axis. Onco Targets Ther. 13:3853–3866. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Sun S, Guo Y, Qin J and Liu G:
Long non-coding RNA MCM3AP-AS1 promotes growth and migration
through modulating FOXK1 by sponging miR-138-5p in pancreatic
cancer. Mol Med. 25:552019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Luo C and Zhang G: lncRNA
MCM3AP-AS1 regulates epidermal growth factor receptor and autophagy
to promote hepatocellular carcinoma metastasis by interacting with
miR-455. DNA Cell Biol. 38:857–864. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Q, Xu H, Zhu J, Feng K and Hu C:
lncRNA MCM3AP-AS1 promotes breast cancer progression via modulating
miR-28-5p/CENPF axis. Biomed Pharmacother. 128:1102892020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: lncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Mao R, Liu C, Zhang W, Tang Y and
Guo Z: lncRNA FAL1 promotes cell proliferation and migration by
acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Life Sci. 197:122–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu Y, Shao QS, Yao HB, Jin Y, Ma YY and
Jia LH: Overexpression of FOXC1 correlates with poor prognosis in
gastric cancer patients. Histopathology. 64:963–970. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu Y, Zhu QN, Deng JL, Li ZX, Wang G and
Zhu YS: Emerging role of long non-coding RNAs in cisplatin
resistance. Onco Targets Ther. 11:3185–3194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Y, Yang S, Han Y, Sun J, Xv L, Wu L and
Ming L: HOXD-AS1 confers cisplatin resistance in gastric cancer
through epigenetically silencing PDCD4 via recruiting EZH2. Open
Biol. 9:1900682019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
An J, Lv W and Zhang Y: lncRNA NEAT1
contributes to paclitaxel resistance of ovarian cancer cells by
regulating ZEB1 expression via miR-194. Onco Targets Ther.
10:5377–5390. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu X, Zhang M, Miao J, Wang X and Huang C:
miRNA-4317 suppresses human gastric cancer cell proliferation by
targeting ZNF322. Cell Biol Int. 42:923–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He X and Zou K: miRNA-96-5p contributed to
the proliferation of gastric cancer cells by targeting FOXO3. J
Biochem. 167:101–108. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu
Y, Li J, Zhang Q, Li Q and Li L: MicroRNA-138 modulates metastasis
and EMT in breast cancer cells by targeting vimentin. Biomed
Pharmacother. 77:135–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu D, Gu L, Li Z, Jin W, Lu Q and Ren T:
miR-138-5p suppresses lung adenocarcinoma cell
epithelial-mesenchymal transition, proliferation and metastasis by
targeting ZEB2. Pathol Res Pract. 215:861–872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang X, Jiang J, Zhu J, He N and Tan J:
HOXA4-regulated miR-138 suppresses proliferation and gefitinib
resistance in non-small cell lung cancer. Mol Genet Genomics.
294:85–93. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li B, Zhao H, Song J, Wang F and Chen M:
LINC00174 down-regulation decreases chemoresistance to temozolomide
in human glioma cells by regulating miR-138-5p/SOX9 axis. Hum Cell.
33:159–174. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
37
|
Chen M, Zhang R, Lu L, Du J, Chen C, Ding
K, Wei X, Zhang G, Huang Y and Hou J: lncRNA PVT1 accelerates
malignant phenotypes of bladder cancer cells by modulating
miR-194-5p/BCLAF1 axis as a ceRNA. Aging (Albany NY).
12:22291–22312. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Y, Li W, Lin Z, Hu J, Wang J, Ren Y,
Wei B, Fan Y and Yang Y: The long noncoding RNA Linc01833 enhances
lung adenocarcinoma progression via miR-519e-3p/S100A4 axis. Cancer
Manag Res. 12:11157–11167. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yun SH, Han SH and Park JI: COUP-TFII
knock-down promotes proliferation and invasion in colorectal cancer
cells via activation of Akt pathway and up-regulation of FOXC1.
Anticancer Res. 40:177–190. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gong R, Lin W, Gao A, Liu Y, Li J, Sun M,
Chen X, Han S, Men C, Sun Y and Liu J: Forkhead box C1 promotes
metastasis and invasion of non-small cell lung cancer by binding
directly to the lysyl oxidase promoter. Cancer Sci. 110:3663–3676.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang H, Xiong Y, Wu Z, He Y, Gao X, Zhou
Z and Wang T: MIR-138-5P inhibits the progression of prostate
cancer by targeting FOXC1. Mol Genet Genomic Med. 8:e11932020.
View Article : Google Scholar : PubMed/NCBI
|
